Abiomed Inc (ABMD):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Abiomed Inc (ABMD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7505
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abiomed Inc (Abiomed) is a provider of mechanical circulatory support devices. It develops, manufactures and markets novel technologies designed to replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes catheters for circulatory support; minimally invasive implantable cardiac assist devices; and percutaneous catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps. Abiomed also offers automated controllers, designed to control and monitor the catheter performance and display real time hemodynamic and catheter position information. It has manufacturing facilities in Danvers, Massachusetts; and Aachen, Germany. The company sells its products through direct sales and distributors in the Americas, Europe, Asia and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.

Abiomed Inc (ABMD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Abiomed Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Abiomed Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Abiomed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Abiomed Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Reprieve Cardiovascular Raises USD7 Million in Venture Financing 11
Magenta Medical Raises USD15 Million in Series B Financing 12
ALung Technologies Raises Funds through Series C Financing 13
Partnerships 15
Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 15
Acquisition 16
Abiomed Acquires ECP from Syscore for USD13 Million 16
Abiomed Inc – Key Competitors 17
Abiomed Inc – Key Employees 18
Abiomed Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Strategy And Business Planning 20
Mar 30, 2017: Abiomed Marks Grand Opening of Newly-Expanded Headquarters in Danvers, Massachusetts 20
Financial Announcements 21
Jul 26, 2018: Abiomed announces Q1 FY 2019 record revenue of $180 million, Up 36% over prior year 21
May 03, 2018: Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year 22
Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year 23
Jan 08, 2018: Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154M, Up 34% Over Prior Year 24
Oct 26, 2017: Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33% 25
Jul 27, 2017: Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year 26
May 04, 2017: Abiomed Announces Q4 FY 2017 Revenue of $124.7 Million, Up 33% Over Prior Year and Total Year Revenue of $445.3 Million, Up 35% Over Prior Year 28
Jan 26, 2017: Abiomed Announces Q3 FY 2017 Revenue of $114.7 Million, Up 34% Over Prior Year 29
Jan 09, 2017: Abiomed Announces Preliminary Q3 FY 2017 Revenue of $114.7 Million, Up 34% Over Prior Year 30
Corporate Communications 31
Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp 31
Aug 28, 2017: Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant 32
Product News 33
Sep 24, 2018: Data presented at TCT 2018 shows use of Impella and best practices increases cardiogenic shock survival 33
Mar 05, 2018: Abiomed Showcases Impella Technology that Enables Heart Recovery at ACC with 25 Presentations 34
Oct 19, 2017: Abiomed’s Impella Technology that Enables Heart Recovery Showcased at TCT 2017 With More Than 30 Presentations 35
Jun 09, 2017: Heart Recovery Patients Visit Capitol Hill to Advocate for Lifesaving Cardiovascular Technology 36
Mar 19, 2017: First-Ever Presentation on Abiomed’s Impella Quality Assurance Program at the 2017 American College of Cardiology Scientific Session 37
Mar 16, 2017: Abiomed’s Impella Technology Showcased at 2017 American College of Cardiology Scientific Session With More Than 10 Presentations 39
Other Significant Developments 41
Feb 13, 2018: Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women’s Initiative for Heart Recovery 41
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Abiomed Inc, Medical Equipment, Key Facts, 2018 2
Abiomed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Abiomed Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Abiomed Inc, Deals By Market, 2012 to YTD 2018 9
Abiomed Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Reprieve Cardiovascular Raises USD7 Million in Venture Financing 11
Magenta Medical Raises USD15 Million in Series B Financing 12
ALung Technologies Raises Funds through Series C Financing 13
Abiomed Enters Into Licensing Agreement With Opsens For Optical Sensor Technology 15
Abiomed Acquires ECP from Syscore for USD13 Million 16
Abiomed Inc, Key Competitors 17
Abiomed Inc, Key Employees 18
Abiomed Inc, Subsidiaries 19

List of Figures
Abiomed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Abiomed Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Abiomed Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Abiomed Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Abiomed Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Abiomed Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Abiomed Inc (ABMD):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Unikai Foods (P.J.S.C):企業の戦略・SWOT・財務分析
    Unikai Foods (P.J.S.C) - Strategy, SWOT and Corporate Finance Report Summary Unikai Foods (P.J.S.C) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • DUAL International Ltd:企業の戦略・SWOT・財務情報
    DUAL International Ltd - Strategy, SWOT and Corporate Finance Report Summary DUAL International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Polymetal International Plc:戦略・SWOT・企業財務分析
    Polymetal International Plc - Strategy, SWOT and Corporate Finance Report Summary Polymetal International Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cal-Maine Foods Inc (CALM):企業の財務・戦略的SWOT分析
    Cal-Maine Foods Inc (CALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • J. Front Retailing Co., Ltd.:戦略・SWOT・企業財務分析
    J. Front Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary J. Front Retailing Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Samuel Heath & Sons Plc:企業の戦略・SWOT・財務情報
    Samuel Heath & Sons Plc - Strategy, SWOT and Corporate Finance Report Summary Samuel Heath & Sons Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • BKW AG:企業の戦略・SWOT・財務分析
    BKW AG - Strategy, SWOT and Corporate Finance Report Summary BKW AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Yes Bank Wealth Management:企業の戦略・SWOT・財務情報
    Yes Bank Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Yes Bank Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bonanza Creek Energy Inc (BCEI):企業の財務・戦略的SWOT分析
    Summary Bonanza Creek Energy Inc (Bonanza Creek) is an exploration and production company, engaged in acquisition, extraction and development of oil and related liquids which are rich in natural gas. The company uses horizontal drilling method for exploration and production of oil and natural gas an …
  • Hamamatsu Photonics KK (6965):企業の財務・戦略的SWOT分析
    Hamamatsu Photonics KK (6965) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Wilmar International Ltd (F34):企業の財務・戦略的SWOT分析
    Wilmar International Ltd (F34) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Follett Corporation:企業の戦略的SWOT分析
    Follett Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • MiMedx Group Inc – Product Pipeline Analysis, 2018 Uate
    Summary MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary pur …
  • Sea Run Holdings Inc:製品パイプライン分析
    Summary Sea Run Holdings Inc (Sea Run Holdings) is a healthcare solutions provider that discovers and develops innovative reagents and therapeutics. The company’s pipeline products include salmon plasma and salmon fibrin products. Its salmon plasma product provides effective treatment for acute pain …
  • Colas SA (RE):企業の財務・戦略的SWOT分析
    Colas SA (RE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Genera Biosystems Ltd (GBI):医療機器:M&Aディール及び事業提携情報
    Summary Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is …
  • Veristat LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Veristat LLC (Veristat), a subsidiary of Veristat Holding Inc is a clinical research organization that conducts clinical trials. The organization offers services such as clinical project management, data management, clinical monitoring, biostatistics, medical writing, project management, reg …
  • Genextra Spa:製薬・医療:M&Aディール及び事業提携情報
    Summary Genextra SpA (Genextra) is a therapies developing company that discovers and develops therapies for age-related and metabolic diseases. The company develops INT-747 for comb, INT- 777 for metabolic syndrome, mono therapy and diabetes, novel HDAC and HSP90 inhibitors for the treatment of canc …
  • ITV plc:企業の戦略・SWOT・財務分析
    ITV plc - Strategy, SWOT and Corporate Finance Report Summary ITV plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • China Resources Enterprise Ltd:企業の戦略的SWOT分析
    China Resources Enterprise Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆